Unique ID issued by UMIN | UMIN000050676 |
---|---|
Receipt number | R000057715 |
Scientific Title | The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture |
Date of disclosure of the study information | 2023/03/25 |
Last modified on | 2024/02/01 11:22:47 |
The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture
MEC of ropivacaine in SFICB
The median effective concentration of ropivacaine for ultrasound-guided suprainguinal fascia iliaca compartment block for preoperative pain management in elderly patients with hip fracture
MEC of ropivacaine in SFICB
Asia(except Japan) |
Inpatients 75 years of age or older with acute hip fracture were recruited into the study.
Geriatrics | Orthopedics | Anesthesiology |
Emergency medicine | Adult |
Others
NO
This study aimed to evaluate the 50% effective concentration (ED50) of ropivacaine to achieve successful preperative pain management for ultrasound-guided suprainguinal fascia iliaca compartment blockade in elderly patients.
Safety,Efficacy
The primary outcomes was a successful analgesia (in the initial 24 hr after procedure, the exercising visual analog scale score < 4).
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
A concentration of 30 ml ropivacaine administered to the suprainguinal fascia iliaca compartment was measured by applying the up and down sequential method. The starting concentration was 0.35 % in the first patient, and increases or decreases in the concentration of ropivacaine were set at 0.025% on the basis of the response of the previous patient (effective or ineffective). The study was concluded when 7 crossovers occurred.
75 | years-old | < |
100 | years-old | >= |
Male and Female
The inclusion criteria were patients 75 years of age or older with acute hip fracture.
The exclusion criteria were 1) weighing less than 35kg, 2) any serious systemic disease, 3) manifesting coagulopathy or receiving anticoagulants, 4) known hypersensitivity to ropivacaine, 5) a history of chronic pain or preoperative chronic use of analgesics, 6) an infection in the area where FICB was to be performed, 7) neurological or neuromuscular disease, and 8) dementia or having significant visual, hearing, or cognitive impairment.
30
1st name | jie |
Middle name | |
Last name | Chen |
Affiliated Banan Hospital of Chongqing Medical University
Department of Anaesthesiology
401320
Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing, China
+81-086-23-66234145
cjandsh@tmmu.edu.cn
1st name | jie |
Middle name | |
Last name | Chen |
Affiliated Banan Hospital of Chongqing Medical University
Department of Anaesthesiology
401320
Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing, China
+81-086-23-66234145
cjandsh@tmmu.edu.cn
Department of Anaesthesiology, Affiliated Banan Hospital of Chongqing Medical University
Department of Anaesthesiology, Affiliated Banan Hospital of Chongqing Medical University
Self funding
Ethics Committee of the Affiliated Banan Hospital of Chongqing Medical University
Yunan Avenue 659, Longzhouwan Street, Banan District, Chongqing 401320, P.R China
+81-086-23-66291798
409560509@qq.com
NO
2023 | Year | 03 | Month | 25 | Day |
Unpublished
28
Completed
2023 | Year | 03 | Month | 17 | Day |
2022 | Year | 11 | Month | 10 | Day |
2023 | Year | 04 | Month | 03 | Day |
2023 | Year | 10 | Month | 25 | Day |
2023 | Year | 03 | Month | 25 | Day |
2024 | Year | 02 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057715
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |